Support Information 1
General Information. 1 H NMR and 13 C NMR spectra were recorded at ambient temperature using 600 MHz, 400 MHz or 300 MHz spectrometers. The data are reported as follows: chemical shift in ppm from internal tetramethylsilane on the δ scale, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constants (Hz) and integration. High resolution mass spectra were were obtained by peak matching. Analytical thin layer chromatography was performed on 0.25 mm extra hard silica gel plates with UV254 fluorescent indicator. Liquid chromatography was performed using forced flow (flash chromatography) of the indicated solvent system on 100-200 Å (40 -60 μm) mesh silica gel (SiO 2 ). All reactions were carried out under an atmosphere of argon in glassware, which had been oven-dried. Unless otherwise noted, all reagents were commercially obtained from Aladdin, Alfa-Asea and Beijing Ouhe company and used directly without further purification. CH 2 Cl 2 , MeCN, THF, Methanol, EtOH, Toluene, 1,4-Dioxane were dried according to the procedure described in the fifth edition of <Purafication of Laboratory Chemicals > by W.L.F. Armarego & C.L.L. Chai. 1 Metal salts were stored in a dry box filled with silica gel. Preparation of R2-b R2-b was prepared following the procedure reported by L. C. Clark. Jr and coworkers. 7 Detailed procedure was below: To a cold solution of KNO 3 (1.21 g, 12 mmol, 1.2 equiv) in 8.0 mL of concentrated H 2 SO 4 was dropwised commercially available 3-chlorobenzaldehyde (1.13 mL, 10 mmol, 1.0 equiv).The resulting mixture was stirred at 0 ℃ overnight. Then the mixture was poured into ice-cooled water, and extracted with dichloromethane (×2), the organic layer was washed with brine (×1), dried over Na 2 SO 4 , filtered and concentrated to afford the crude product, which was further puried by column chromatography with hexanes:EtOAc/20:1 to afford the product R2-b as an white solid (1.6 g, 86%).
Preparation of R3-b R3-b was prepared following the procedure of the preparation of R3-a using 1.52 g of R2-b (8.19 mmol), 3.0 mL of AcOH, 3.0 mL of water, and 20.0 mL of acetone, and 2.75 g of iron powder (49.2 mmol). Purification by column chromatography with hexanes:EtOAc/10:1 afforded the product R3-b as a yellow solid (714 mg, 56%).
ortho-Azidobenzaldehyde S6. The general procedure D was followed using 714 mg of R3-b (4.6 mmol), 476 mg of sodium nitrite (6.9 mmol), and 449 mg of sodium azide (6.9 mmol) in 3.0 mL of H 2 O and 3.0 mL of AcOH. Purification by column chromatography with hexanes:EtOAc/20:1 afforded the final analytically pure S6 as a slightly yellow solid (668 mg, 80%).
Procedure D:
Diazotization and Further Substitution with Sodium Azide Unless otherwise noted, the requisite azides were prepared in one step from substituted 2-aminobenzophenones following the procedure reported by Driver. T. G. and co-workers (eq. e4) 6, 8 . The yields were not optimized.
To a cold solution of substituted 2-aminobenzophenone (10.0 mmol, 1.0 equiv) in 10 mL of acetic acid and 10 mL of water was added sodium nitrite (1.04 g, 15.0 mmol, 1.5 equiv). After stirring for 1 hour, sodium azide (0.975 g, 15.0 mmol, 1.5 equiv) was added slowly into the stirring mixture, and the mixture was allowed to warm to ambient temperature. After an additional hour of stirring, the resulting mixture was neutralized with a saturated aqueous solution of Na 2 CO 3 and extracted with dichloromethane (×2). The resulting organic phase was dried over Na 2 SO 4 , filtered and concentrated to give the crude product. Purification by column chromatography afforded the final analytically pure product.
ortho-Azidoketone S7. The general procedure D was followed using 1.97 g of commercially Chloroalkenal T4. The general procedure was followed using 0. Chloroalkenal T5. The general procedure was followed using 0. 
5367-5376.
Chloroalkenal T6. The general procedure was followed using 0. Chloroalkenal T7. The general procedure was followed using 0.6 g of phenylacetophenone Chloroalkenal T8. The general procedure was followed using 0.53 mL of ethyl phenyl ketone Chloroalkenal T9. The general procedure was followed using 1.04 mL of cyclohexanone (10.0 mmol) ， 1. Chloroalkenal T10. The general procedure was followed using 1.33 mL of α-tetralone(10.0 mmol) ， 1.9 mL of POCl 3 (20.0 mmol), and 4.0 ml of DMF. Purification by column chromatography with Hexanes:EtOAc/20:1 afforded T10 as a slightly yellow oil (1.4 g, 73%).
(Caution: the reaction should be carried at room temperature for the product is volatile.) For the characterizeation ( 1 H NMR) of T10 see: Tom G. Driver*, Org Lett, 2010, 12, 2884-2887.
III Preparation of 3-Azido-2-Alkenals A. General Procedure for the Preparation 3-Azido-2-Alkenals
Unless otherwise noted, 3-azido-2-alkenals were synthesized from the corresponding substituted 3-chloro-2-alkenals using nucleophilic substitution with sodium azide following the procedure reported by Tom. G. Driver* and co-workers (eq. E2). 8 Yields were not optimized.
To a solution of 3-chloro-2-propenal (2.0 mmol, 1.0 equiv) in 3.0mL of DMSO was added NaN 3 (2.4 mmol, 1.2 equiv). The mixture was stirred at ambient temperature with aluminum foil wrapped to avoid light and was monitored by TLC. Once the starting material disappeared, the reaction mixture was diluted with water (30.0 mL) and extracted with dichloromethane(10 mL×2). The DCM layer was washed with water (10 mL×2), brine (20 mL×1). The organic layer was dried over Na 2 SO 4 , filtered and concentrated to afford the crude product. Rapid purification by column chromatography with hexanes/EtOAc/(1%v)Et 3 N to afford the final analytically pure product. (Caution: these azides are unstable to silica gel and volatile when open to air).
B. 3-Azido-2-Alkenal Synthesis
Azidoaldehyde S11. The general procedure was followed using 90 mg of chloroalkenal T1
(0.50 mmol), 39 mg of NaN 3 (0.6 mmol) and 2.0 mL of DMSO. Purification by column chromatography with hexanes:EtOAc/15:1(1%v Et 3 N) to give S11 as a yellow oil (65 mg, 69% Azidoaldehyde S12. The general procedure was followed using 396 mg of chloroalkenal T2 (2.0 mmol), 157 mg of NaN 3 (2.4 mmol) and 4.0 mL of DMSO. Purification by column chromatography with hexanes:EtOAc/10:1(1%v Et 3 N) to give S12 as a slightly yellow oil (172 mg, 42% Azidoaldehyde S15. The general procedure was followed using 106 mg of chloroalkenal T5
(0.5 mmol), 39 mg of NaN 3 (0.6 mmol) and 2. Azidoaldehyde S18. The general procedure was followed using 240 mg of chloroalkenal T8
(1.33 mmol), 104 mg of NaN 3 (1.60 mmol) and 2.5 mL of DMSO. Purification by column chromatography with hexanes:EtOAc/10:1(1%v Et 3 N) to give S18 as a yellow oil (227 mg, 91% 12 To a 0 ℃ solution of ortho-azidobenzketone (1.0 equiv) in 2.0 mL anhydrous DCM was added aniline (1.0 equiv), TiCl 4 (0.6 equiv), Et 3 N(3.0 equiv). The resulting mixture was stirred at 0 ℃ for 0.5 h-1 h. When the starting materials appeared, a cooled saturated solution of NaHCO 3 was added to quench the reaction and filter to remove the solid TiO 2 . The solution was extracted with DCM (×2), the DCM layer was washed with water (×1), brine (×1). The organic layer was dried over Na 2 SO 4 , filtered and evaporated to give the crude product, which was further dried in vaccum.
(Caution: Product of step1 schiff base was unstable to untreated silica gel. So after optimization, the yield of two step procedure was higher than separated two procedures) C. General procedure for the optimization of the reaction condition 2.
To a diluted solution of the crude product of step1 in 1.0 mL solvent was added crushed 4Å molecular sieves (100 wt %), catalyst (0.1-1.0 equiv), additive (0.1-1.0 equiv). After 4 h, the heterogenous mixture was filtered through SiO 2 . The filtrate was concentrated in vacuo and diluted in equal 1.0 mL dichloromethane, each added equal ortho-hydroxyacetophenone (as internal standard). Compare the area of peak of indazole 2 and ortho-hydroxyacetophenone to give the relative values. Once getting one actual yield, we afforded other yields.
D. Optimized two step typical procedure 6
Step1: The generation of Schiff base followed the general procedure a or b. The solution was concentrated in vacuo once more to afford crude ortho-azidoarylimine .
Step2: To the unpurified product Schiff base, 1.0-2.0 mL of THF or 1,4-dioxane, crushed 4Å molecular sieves (100 wt%), CuI (0.1 equiv) and TMEDA (0.5 equiv) or Et 3 N (1.0 equiv) was added. The resulting mixture was stirred at room temperature for 4 h or 40 ℃ for 2 h. The reaction mixture was cooled to room temperature, and the heterogenous mixture was filtered through SiO 2 .
The filtrate was concentrated in vacuo. Purification by column chromatography provided the indazoles (2-28). E. Indazole synthesis from aryl azidos S1-S10 (two step procedure)
2-(4-methoxyphenyl)-2H-indazole (2)
The typical procedure was followed using 40 mg of 2-azidobenazldehyde S1 ( 
2-p-tolyl-2H-indazole (3)
The typical procedure was followed using 40 mg of 2-azidobenazldehyde S1 (0.272 mmol, 1. 
2-(4-fluorophenyl)-2H-indazole (4)
The typical procedure was followed using 40 mg of 2-azidobenazldehyde S1 (0.272 mmol, 1. 212.99.
2-(4-nitrophenyl)-2H-indazole (5)
The typical procedure was followed using 60 mg of 2-azidobenazldehyde S1 (0.408 mmol, 1. 
2-(3-(trifluoromethyl)phenyl)-2H-indazole (6)
2-(pyridin-2-yl)-2H-indazole (7) Electronic Supplementary Material (ESI) for Chemical Communications This journal is © The Royal Society of Chemistry 2011
The typical procedure was followed using 40 mg of 2-azidobenazldehyde S1 (0. 
2-(naphthalen-1-yl)-2H-indazole (8)
2-benzyl-2H-indazole (9)
The typical procedure was followed using 40 mg of 2-azidobenazldehyde S1 (0.272 mmol, 1.1 equiv), 27.0 μL of benzylamine (0.247 mmol, 1.0 equiv), 4.0 μL of AcOH (0.074 mmol, 0.3 equiv), 3.0 mL of MeOH. 4.7 mg of CuI (0.0247 mmol, 0.1 equiv), 18.5 μL of TMEDA (0.124 mmol, 0.5 equiv), crushed 4Å molecular sieves and 1.5 mL of THF was used in the next step. Purification by column chromatography with hexanes:EtOAc/15:1 afforded 9 as an white solid (48 mg, 93% 
5-bromo-2-(4-chlorophenyl)-2H-indazole (10)
The typical procedure was followed using 40 mg of 2-azido- 
5-bromo-2-(4-methoxyphenyl)-2H-indazole (11)
The typical procedure was followed using 40 mg of 2-azido-5-bromobenazldehyde S3 (0. 
5-bromo-2-(2,5-dimethylphenyl)-2H-indazole (12)
5-bromo-2-(4-bromophenyl)-2H-indazole (13)
The typical procedure was followed using 40 mg of 2-azido-5-bromobenazldehyde S3 (0.177 mmol, 1. 
6-bromo-2-(4-methoxyphenyl)-2H-indazole (14)
The typical procedure was followed using 40 mg of 2-azido-4-bromoaldehyde S4 (0.177 mmol, 302.93.
6-bromo-2-(4-chlorophenyl)-2H-indazole (15)
The typical procedure was followed using 40 mg of 2-azido-4-bromoaldehyde S4 (0.177 mmol, 
5-chloro-2-(4-methoxyphenyl)-2H-indazole (17)
The typical procedure was followed using 30 mg of 2-azido-5-chloroaldehyde S6 (0.165 mmol, 1.1 equiv), 18.5 mg of 4-methoxyaniline (0.15 mmol, 1.0 equiv), 2.6 μL of AcOH (0.045 mmol, 0.3 equiv), 2.0 mL of MeOH. 2.9 mg of CuI (0.015 mmol, 0.1 equiv), 11.0 μL of TMEDA (0.075 mmol, 0.5 equiv), crushed 4Å molecular sieves and 2.0 mL of THF was used in the next step. Purification by column chromatography with hexanes:EtOAc/20:1 afforded 17 as an white solid (35 mg, 90% 
2-(4-bromophenyl)-2H-[1,3]dioxolo[4,5-f]indazole (18)
The typical procedure was followed using 40 mg of 6-azidopiperonal S2 (0. 
2-(4-fluorophenyl)-2H-[1,3]dioxolo[4,5-f]indazole (19)
2-(4-methoxyphenyl)-3-phenyl-2H-indazole (20)
The typical procedure was followed using 34 mg of (2-azidophenyl)(phenyl)methanone S7 (0. 
2-(4-nitrophenyl)-3-phenyl-2H-indazole (21)
The typical procedure was followed using 76 mg of (2-azidophenyl)(phenyl)methanone S7 (0 
5-chloro-2-(4-methoxyphenyl)-3-phenyl-2H-indazole (22)
The typical procedure was followed using 67 mg of (2-azido-5-chlorophenyl)(phenyl) methanone S8 (0.26 mmol, 1. 
2-(4-bromophenyl)-5-chloro-3-phenyl-2H-indazole (23)
The typical procedure was followed using 40 mg of (2- 
5-chloro-3-phenyl-2-p-tolyl-2H-indazole (24)
2-(4-fluorophenyl)-3,5-dimethyl-2H-indazole (25)
The typical procedure was followed using 47 mg of 1- 241.11, found: 241.22.
2-(4-methoxyphenyl)-3,5-dimethyl-2H-indazole (26)
The typical procedure was followed using 25 mg of 1- 
5-methoxy-2-(4-methoxyphenyl)-3-methyl-2H-indazole (27)
The typical procedure was followed using 33 mg of 1-(2-azido-5-methoxyphenyl)ethanone S10 
5-methoxy-3-methyl-2-p-tolyl-2H-indazole (28)
The typical procedure was followed using 44 mg of 1-(2-azido-5-methoxyphenyl)ethanone S10 Step1: To a solution of vinylazidobenazldehydes S11-S20 (1.2 equiv) in 1.0 mL anhydrous EtOH or MeOH was added aryl anline (1.0 equiv) and dropwised AcOH (0.1-0.3 equiv). The resulting mixture was stirred at ambient temperature for 2-8 h. Once the starting materials disappeared mostly on TLC, the solution was evaporated to give the crude product, which was further dried in vaccum.
Step2: To the unpurified product Schiff base, 1.0 mL of THF , crushed 4Å molecular sieves (100 wt%), CuI (0.1 equiv) and Et 3 N (1.0 equiv) was added. The resulting mixture was stirred at room temperature for 4 h or 40℃ for 2 h. The reaction mixture was cooled to room temperature, and the heterogenous mixture was filtered through SiO 2 . The filtrate was concentrated in vacuo. Purification by column chromatography provided the pyrazoles (29-45). C. Pyrazole synthesis from aryl azidos S11-S20.
3-(4-methoxyphenyl)-1-p-tolyl-1H-pyrazole (29)
The typical procedure was followed using 35 mg of (Z) 
1-(4-bromophenyl)-3-(4-methoxyphenyl)-1H-pyrazole (30)
The typical procedure was followed using 27 mg of (Z)-3-azido-3-(4-methoxyphenyl) acrylaldehyde S12 (0.137 mmol, 1.1 equiv), 22 mg of 4-bromoaniline (0.125 mmol, 1.0 equiv), .8, 153.2, 139.3, 132.5, 127.8, 127.2, 125.7, 120.3, 119.3, 114.2, 105.1 
1-(4-methoxyphenyl)-3-p-tolyl-1H-pyrazole (31)
The typical procedure was followed using 62 mg of (Z)-3-azido-3-p-tolylacrylaldehyde S11 (0. 265.06.
1-(4-bromophenyl)-3-p-tolyl-1H-pyrazole (32)
The typical procedure was followed using 67 mg of (Z)-3-azido-3-p-tolylacrylaldehyde S11 (0. 
1-(2-methoxyphenyl)-3-(4-nitrophenyl)-1H-pyrazole (34)
The typical procedure was followed using 27 mg of Z/E mixture of 3-azido-3-(4-nitro phenyl)acrylaldehyde S13 (0.124 mmol, 1.1 equiv), 12. 
1-(4-fluorophenyl)-3-(3-nitrophenyl)-1H-pyrazole (35)
The typical procedure was followed using 49.5 mg of Z/E mixture of 3-azido-3-(3-nitrophenyl) acrylaldehyde S15 (0.227 mmol, 1. 
1-(2-fluorophenyl)-3-(4-fluorophenyl)-1H-pyrazole (36)
The typical procedure was followed using 47 mg of (Z) 
1-(4-methoxyphenyl)-3-(naphthalen-1-yl)-1H-pyrazole (37)
The typical procedure was followed using 49 mg of Z/E mixture of 3-azido-3-(naphthalen-1-yl)acrylaldehyde S16 (0.22 mmol, 1.1 equiv), 24.6 mg of 4-methoxyaniline (0. 
1-(4-methoxyphenyl)-3,4-diphenyl-1H-pyrazole (38)
The typical procedure was followed using 36 mg of Z/E mixture of 3-azido-2,3-diphenyl acrylaldehyde S17 (0.143 mmol, 1.1 equiv), 16 mg of 4-methoxyaniline (0. 
1-(4-bromophenyl)-3,4-diphenyl-1H-pyrazole (39)
The typical procedure was followed using 36 mg of Z/E mixture of 3-azido-2,3-diphenyl acrylaldehyde S17 (0.143 mmol, 1. 
1-(2,5-dimethoxyphenyl)-3,4-diphenyl-1H-pyrazole (40)
The typical procedure was followed using 36 mg of Z/E mixture of 3-azido-2,3-diphenyl acrylaldehyde S17 (0.143 mmol, 1.1 equiv), 20 mg of 2,5-dimethoxyaniline (0.13 mmol, 1.0 equiv), 2. 
1-(4-chlorophenyl)-4-methyl-3-phenyl-1H-pyrazole (41)
The typical procedure was followed using 60 mg of Z/E mixture of 3-azido-2-methyl-3-phenylacrylaldehyde S18 ( 
1-(4-methoxyphenyl)-4-methyl-3-phenyl-1H-pyrazole (42)
The typical procedure was followed using 223 mg of Z/E mixture of 3-azido-2-methyl-3-phenylacrylaldehyde S18 ( 
4-methyl-1-(naphthalen-1-yl)-3-phenyl-1H-pyrazole (43)
The typical procedure was followed using 206 mg of Z/E mixture of 3-azido-2-methyl-3-phenylacrylaldehyde S18 (1. 
2-(3-(trifluoromethyl)phenyl)-4,5-dihydro-2H-benzo[g]indazole (45)
The typical procedure was followed using 59 mg of 1-chloro-3,4-dihydronaphthalene-2-carbaldehyde S20 (0.298 mmol, 1. 
VI. Application: Synthesis of Selective Ligand for Estrogen Receptor β
The procedure mainly contains three-step independent reactions from the starting material o-azidobenzaldehyde 46 (S5) (Condition a, b and c ).
General synthetic route to Selective Ligand for Estrogen Receptor β
Detailed procedures were below:
A. Preparation of 48 (Indazole formation: Condition a)
Step1: To a solution of ortho-azidobenazldehyde 46 (60 mg, 0.271 mmol, 1.05 equiv) in 2.5 mL anhydrous MeOH was added p-aminophenol 47 (28.2 mg, 0.258 mmol, 1.0 equiv) and dropwised AcOH (4.4 μL , 0.0774 mmol, 0.3 equiv). The resulting mixture was stirred at ambient temperature for 2 h. The solution was evaporated to give the crude product, which was further dried in vaccum.
Step2: To the unpurified schiff base, 2.0 mL of THF, crushed 4Å molecular sieves (100 wt%), CuI (4.9 mg, 0.0258 mmol, 0.1 equiv) and TMEDA (19.3 μL, 0.129 mmol, 0.5 equiv) was added. The resulting mixture was heated to 40℃. After 2 h, the reaction mixture was cooled to room temperature, and the heterogenous mixture was filtered through SiO 2 . The filtrate was concentrated in vacuo. Purification by column chromatography provided 48 as an white solid (31 mg, 42% C. Preparation of 50 ( Deprotection: Condition c) 13 To a 30 mg of 49 (0.094 mmol, 1.0 equiv) in 3.0 mL of THF/H 2 O (2:1) was added 37.6 mg of NaOH (0.94 mmol, 10.0 equiv) in 0.5 mL of water. After 0.5 h, 1M HCl was added to make the pH ≈ 4.0. The aqueous layer was extracted with DCM (×3). The combined organic layer was dried over Na 2 SO 4 , filtered and evaporated to give the crude product. Purification by column chromatography afforded 50 as an white solid (25 mg, 95% 
